Geriatric Patients (65 years and older): Start with a lower dose, such as 15 mg IM or IV, and carefully monitor for side effects. Reduced renal function is common in this population, potentially increasing the risk of adverse events.
Patients with Renal Impairment: Reduce the dosage based on creatinine clearance. Consult prescribing information for specific guidelines. Closely monitor for signs of toxicity. Consider alternative analgesics if necessary.
Patients with Hepatic Impairment: While Toradol is primarily metabolized renally, monitor closely for any unusual response or prolonged effects. A lower starting dose may be appropriate.
Patients with Cardiac Disease: Use caution. Toradol can influence blood pressure and fluid balance. Careful monitoring of vital signs is necessary. Consider potential drug interactions with existing cardiac medications.
Pediatric Patients: Toradol is generally not recommended for children under 12 years old. Safer alternatives are usually preferred.
Pregnant and Breastfeeding Women: Use only when the benefits clearly outweigh the potential risks. Close monitoring is required. Consult relevant prescribing guidelines for additional information.
Always consult the most up-to-date prescribing information and consider patient-specific factors before administering Toradol. Individualized dosage adjustments are frequently necessary.
